Drug profile · INN
ampicillin sodium
AMPICILLIN SODIUM
ampicillin sodium (AMPICILLIN SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Solid Biosciences. Route of administration: injection. Current US regulatory status: approved.
Drug details — ampicillin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 1
- Programs
- 2
- Data quality
- 0.89
Quick answer
ampicillin sodium (AMPICILLIN SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Solid Biosciences. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is ampicillin sodium?
ampicillin sodium (AMPICILLIN SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Solid Biosciences. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ampicillin sodium?
AMPICILLIN SODIUM is a marketed brand name for ampicillin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ampicillin sodium?
ampicillin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.